BIOCONManufacturing•prnewswire•
Biocon Inaugurates First U.S. Manufacturing Facility in Cranbury, New Jersey
Sentiment:Positive (70)
Summary
(BIOCON) CRANBURY, N.J. and BENGALURU, India, Sept. 10, 2025 /PRNewswire/ -- Biocon Limited (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceutical company, today announced the inauguration of its first U.S. manufacturing facility in Cranbury, New Jersey, by its wholly owned...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 10, 2025 by prnewswire